Oncology Pharma Inc.
OTC: ONPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- George Malesek
- Employees
- 1
- Headquarters
- San Francisco, United States
- IPO year
- 1994
- Market cap
- $1.7M
- Website
- https://www.oncology-pharma.com
Loading ONPH…
Loading profile data…Frequently asked questions about ONPH
What does Oncology Pharma Inc. (ONPH) do?
Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the comp...
Where does ONPH trade?
Oncology Pharma Inc. (ONPH) trades on the Other OTC.
What sector is ONPH in?
Oncology Pharma Inc. (ONPH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oncology Pharma Inc.?
George Malesek is the chief executive officer of Oncology Pharma Inc. (ONPH).
Where is Oncology Pharma Inc. headquartered?
Oncology Pharma Inc. is headquartered in United States.
Does ONPH pay a dividend?
Oncology Pharma Inc. (ONPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ONPH go public?
Oncology Pharma Inc. (ONPH) completed its initial public offering in 1994.